Ika Rahayu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ika Rahayu has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Kris Herawan Timotius
Department of Biochemistry and Biomolecular, Faculty of Medicine and Health Sciences, Universitas Kristen Krida Wacana, Jakarta, Indonesia
7 shared publications - Mae Sri Hartati Wahyuningsih
Department of Pharmacology and Therapy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 shared publications - Nur Arfian
Department of Anatomy, Faculty of Medicine, Public Health and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia
2 shared publications Susana Elya Sudrajat
Department of Pharmacology, Faculty of Medicine, Universitas Kristen Krida Wacara (UKRIDA) / Research Center for Jamu and Herbal Medicine (Ja-He), Universitas Kristen Krida Wacana (UKRIDA)
2 shared publicationsA. Aridarma
PT. Tesena Inovindo, Susukan, Jakarta 13750, Indonesia
1 shared publication- Adelina Simamora
Department of Biochemistry, Faculty of Medicine and Health Sciences, Krida Wacana Christian University, Jakarta, Indonesia
1 shared publication
Latest Publications
- Open Access
- 30 July 2026
- Published by SAGE Publications in Journal of Applied Pharmaceutical Science
- Vol. 16 (9) , 889-903
Potential Renoprotective Effects of Physalis angulata L. Active Fraction on Podocytopathy, Inflammation, Tubular Injury, and Fibrosis in a Diabetic Nephropathy Rat Model
Diabetic nephropathy (DN), a major complication of diabetes mellitus, is driven by chronic hyperglycemia that induces podocyte injury, inflammation, and oxidative stress, leading to tubular damage and renal fibrosis. Physalis angulata L. (PA) is a medicinal plant with antidiabetic, vasoprotective, antioxidative, and anti-inflammatory activities. This study investigated the effects of the PA active fraction on DN-related renal alterations, particularly podocytopathy, glomerulosclerosis, tubular injury, and fibrosis. Male Wistar rats (200–250 g) were induced with diabetes using streptozotocin (60 mg/kg, i.p.) and divided into control, diabetic, and PA-treated diabetic groups receiving 8.5, 34, or 136 mg/kg of the PA active fraction. Blood glucose was monitored biweekly, while 24-h urinary parameters and creatinine clearance were assessed to evaluate renal function. Renal injury and fibrosis were examined using periodic acid-Schiff and Sirius Red staining. Antioxidative, inflammatory, podocyte, and epithelial-mesenchymal transition, fibrotic markers were analyzed by polymerase chain reaction. Myofibroblast activation was evaluated by immunohistochemistry and Western blot. PA treatment did not significantly affect glycemia, microalbuminuria, or creatinine clearance, but reduced urine albumin-to-creatinine ratio, decreased the expression of transforming growth factor-beta (TGF-β), vimentin, and tumor necrosis factor-alpha, increased nephrin and superoxide dismutase 1/2 expression, and reduced alpha-smooth muscle actin and platelet-derived growth factor receptor beta expression. Histological analysis also showed lower glomerulosclerosis and reduced interstitial fibroblast/myofibroblast expansion in PA-treated diabetic rats. Taken together, the PA active fraction showed potential renoprotective effects against DN-related histological and molecular alterations, while definitive improvement in renal function and direct TGF-β/Smad pathway inhibition remain to be demonstrated in future studies.
- 30 July 2026
- Published by SAGE Publications in Journal of Applied Pharmaceutical Science
- Vol. 16 (9) , 889-903
Open AccessPotential Renoprotective Effects of Physalis angulata L. Active Fraction on Podocytopathy, Inflammation, Tubular Injury, and Fibrosis in a Diabetic Nephropathy Rat Model
Diabetic nephropathy (DN), a major complication of diabetes mellitus, is driven by chronic hyperglycemia that induces podocyte injury, inflammation, and oxidative stress, leading to tubular damage and renal fibrosis. Physalis angulata L. (PA) is a medicinal plant with antidiabetic, vasoprotective, antioxidative, and anti-inflammatory activities. This study investigated the effects of the PA active fraction on DN-related renal alterations, particularly podocytopathy, glomerulosclerosis, tubular injury, and fibrosis. Male Wistar rats (200–250 g) were induced with diabetes using streptozotocin (60 mg/kg, i.p.) and divided into control, diabetic, and PA-treated diabetic groups receiving 8.5, 34, or 136 mg/kg of the PA active fraction. Blood glucose was monitored biweekly, while 24-h urinary parameters and creatinine clearance were assessed to evaluate renal function. Renal injury and fibrosis were examined using periodic acid-Schiff and Sirius Red staining. Antioxidative, inflammatory, podocyte, and epithelial-mesenchymal transition, fibrotic markers were analyzed by polymerase chain reaction. Myofibroblast activation was evaluated by immunohistochemistry and Western blot. PA treatment did not significantly affect glycemia, microalbuminuria, or creatinine clearance, but reduced urine albumin-to-creatinine ratio, decreased the expression of transforming growth factor-beta (TGF-β), vimentin, and tumor necrosis factor-alpha, increased nephrin and superoxide dismutase 1/2 expression, and reduced alpha-smooth muscle actin and platelet-derived growth factor receptor beta expression. Histological analysis also showed lower glomerulosclerosis and reduced interstitial fibroblast/myofibroblast expansion in PA-treated diabetic rats. Taken together, the PA active fraction showed potential renoprotective effects against DN-related histological and molecular alterations, while definitive improvement in renal function and direct TGF-β/Smad pathway inhibition remain to be demonstrated in future studies.
- Open Access
- 28 December 2025
- Published by Universitas Islam Indonesia (Islamic University of Indonesia) in Jurnal Kedokteran dan Kesehatan Indonesia
- p. 383-399
In silico study of the bioactive compounds in Peronema canescens Jack (Sungkai) leaf infusion targeting VEGFR-2: Insights into anticancer potential
Background: Peronema canescens Jack, commonly known as sungkai, is a medicinal plant traditionally consumed as a herbal infusion. It has demonstrated potential anticancer properties attributed to its bioactive constituents, particularly clerodane-type diterpenoids known as peronemins. The anticancer potential of these compounds can be preliminarily explored using in silico approaches. Of particular interest are the reported the cytotoxic effects of sungkai leaves against cancer cell lines and their interactions with angiogenesis-related targets, including vascular endothelial growth factor receptor-2 (VEGFR-2). VEGFR-2 is a critical tyrosine kinase receptor that regulates angiogenesisa and Its aberrant activation contributes to tumor growth and metastasis. Consequently, VEGFR-2 represents a well-established target for anticancer therapy development. Objectives: This study aims to investigate the bioactive compounds present in sungkai leaf infusion using liquid chromatography-mass spectrometry (LC-MS), and to predict their interactions with VEGFR-2 through in silico molecular docking analysis. Methods: Phytochemical profiling of the leaf infusion was conducted using LC-MS. Molecular docking was performed using PyRx 0.8 integrated with AutoDock Vina to assess ligand-protein interactions between selected compounds and VEGFR-2 (PDB ID: 2QU5). The resulting interactions were visualized using Discovery Studio.Results: LC-MS analysis identified ten major compounds in the leaf infusion, consisting of one alkaloid (gentiatibetine) and nine flavonoids. Molecular docking analysis revealed that genkwanin and acacetin-7-galactoside exhibited strong binding affinities toward VEGFR-2 (−9.6 and −9.2 kcal/mol, respectively), approaching that of the referencesorafenib (−11.2 kcal/mol). Both compounds interacted with key catalytic residues, suggesting their potential to inhibit VEGFR-2 by stabilizing its inactive conformation.Conclusion: This study provides the first to report that sungkai leaf infusion is rich in flavonoid compounds two of which exhibit strong anti-VEGFR-2 activity. These findings suggest the potential of sungkai leaf infusion as a natural anticancer agent and support the needfor further in vitro and in vivo validation.
- 28 December 2025
- Published by Universitas Islam Indonesia (Islamic University of Indonesia) in Jurnal Kedokteran dan Kesehatan Indonesia
- p. 383-399
Open AccessIn silico study of the bioactive compounds in Peronema canescens Jack (Sungkai) leaf infusion targeting VEGFR-2: Insights into anticancer potential
Background: Peronema canescens Jack, commonly known as sungkai, is a medicinal plant traditionally consumed as a herbal infusion. It has demonstrated potential anticancer properties attributed to its bioactive constituents, particularly clerodane-type diterpenoids known as peronemins. The anticancer potential of these compounds can be preliminarily explored using in silico approaches. Of particular interest are the reported the cytotoxic effects of sungkai leaves against cancer cell lines and their interactions with angiogenesis-related targets, including vascular endothelial growth factor receptor-2 (VEGFR-2). VEGFR-2 is a critical tyrosine kinase receptor that regulates angiogenesisa and Its aberrant activation contributes to tumor growth and metastasis. Consequently, VEGFR-2 represents a well-established target for anticancer therapy development. Objectives: This study aims to investigate the bioactive compounds present in sungkai leaf infusion using liquid chromatography-mass spectrometry (LC-MS), and to predict their interactions with VEGFR-2 through in silico molecular docking analysis. Methods: Phytochemical profiling of the leaf infusion was conducted using LC-MS. Molecular docking was performed using PyRx 0.8 integrated with AutoDock Vina to assess ligand-protein interactions between selected compounds and VEGFR-2 (PDB ID: 2QU5). The resulting interactions were visualized using Discovery Studio.Results: LC-MS analysis identified ten major compounds in the leaf infusion, consisting of one alkaloid (gentiatibetine) and nine flavonoids. Molecular docking analysis revealed that genkwanin and acacetin-7-galactoside exhibited strong binding affinities toward VEGFR-2 (−9.6 and −9.2 kcal/mol, respectively), approaching that of the referencesorafenib (−11.2 kcal/mol). Both compounds interacted with key catalytic residues, suggesting their potential to inhibit VEGFR-2 by stabilizing its inactive conformation.Conclusion: This study provides the first to report that sungkai leaf infusion is rich in flavonoid compounds two of which exhibit strong anti-VEGFR-2 activity. These findings suggest the potential of sungkai leaf infusion as a natural anticancer agent and support the needfor further in vitro and in vivo validation.
- Open Access
- 19 June 2024
- Published by Maad Rayan Publishing Company in BioImpacts
- Vol. 15 (1) , 30129
The effectiveness of antioxidant agents in delaying progression of diabetic nephropathy: A systematic review of randomized controlled trials
Introduction: Oxidative stress plays a central role in the pathophysiology of diabetes mellitus and its complications, including diabetic nephropathy. Excessive production of reactive oxygen species (ROS) alters renal metabolic pathways, leading to inflammation, endothelial dysfunction, and fibrosis, ultimately resulting in end-stage renal disease (ESRD). Studies have shown that exogenous antioxidants can improve the pathophysiological condition of patients with diabetic nephropathy. Objective: This systematic review aims to investigate the types of antioxidant agents that inhibit the development of diabetic nephropathy and the effectiveness of antioxidant agent interventions to repair kidney structure and function. Methods: A systematic review of randomized controlled trials that examined the role of antioxidants in improving diabetic nephropathy was conducted. The literature search was performed on PubMed, ScienceDirect, and EBSCO. The inclusion criteria covered articles on the antioxidant activity of herbal extracts and compounds that inhibit the progression of diabetic nephropathy in humans. In addition, the articles were written in English and published between 2012 and 2022. The reporting of the systematic review followed the Preferred Reporting Elements for Systematic Review and Meta-Analysis (PRISMA) guideline. The full texts of all potentially relevant systematic reviews were assessed for quality using the Risk of Bias 2 (RoB 2) tool. Results: A total of 2,367 articles were identified in the three databases, of which only 15 articles met the inclusion criteria. Antioxidant agents that inhibit diabetic nephropathy can be classified as single antioxidants (silymarin, baicalin, epigallocatechin gallate, vitamin E, selenium, curcumin, α-lipoic acid, and tocotrienol-rich vitamin E) and combined antioxidants (α-lipoic acid with vitamin B6, and resveratrol with losartan). Antioxidant agents have been shown to reduce oxidative stress and inflammation, but their role in the progression of fibrosis remains unclear. The oxidative stress marker MDA was significantly reduced by silymarin, curcumin, vitamin E, tocotrienol-rich vitamin E, selenium, ALA, vitamin B, resveratrol and losartan. Silymarin was found to be the most effective (-3.43 µmol/L; 6.02 to 0.83). Compared to silymarin and epigallocatechin gallate, vitamin E was more effective (at -35.4 ng/L; P < 0.001) in reducing inflammation by decreasing TNF-α levels. In addition, tocotrienol-rich vitamin E, silymarin, baicalin, and selenium showed a decrease TGF-β levels, but did not show statistically significant differences between the placebo and intervention groups. Conclusion: Potential antioxidant agents, such as flavonoids, vitamins, fatty acids, and antioxidant minerals, were examined in this systematic review. These agents contribute to reducing markers of oxidative stress and hyperglycemia-induced inflammation. Although several antioxidants play a role in reducing fibrosis markers, the effect does not appear to be statistically significant.
- 19 June 2024
- Published by Maad Rayan Publishing Company in BioImpacts
- Vol. 15 (1) , 30129
Open AccessThe effectiveness of antioxidant agents in delaying progression of diabetic nephropathy: A systematic review of randomized controlled trials
Introduction: Oxidative stress plays a central role in the pathophysiology of diabetes mellitus and its complications, including diabetic nephropathy. Excessive production of reactive oxygen species (ROS) alters renal metabolic pathways, leading to inflammation, endothelial dysfunction, and fibrosis, ultimately resulting in end-stage renal disease (ESRD). Studies have shown that exogenous antioxidants can improve the pathophysiological condition of patients with diabetic nephropathy. Objective: This systematic review aims to investigate the types of antioxidant agents that inhibit the development of diabetic nephropathy and the effectiveness of antioxidant agent interventions to repair kidney structure and function. Methods: A systematic review of randomized controlled trials that examined the role of antioxidants in improving diabetic nephropathy was conducted. The literature search was performed on PubMed, ScienceDirect, and EBSCO. The inclusion criteria covered articles on the antioxidant activity of herbal extracts and compounds that inhibit the progression of diabetic nephropathy in humans. In addition, the articles were written in English and published between 2012 and 2022. The reporting of the systematic review followed the Preferred Reporting Elements for Systematic Review and Meta-Analysis (PRISMA) guideline. The full texts of all potentially relevant systematic reviews were assessed for quality using the Risk of Bias 2 (RoB 2) tool. Results: A total of 2,367 articles were identified in the three databases, of which only 15 articles met the inclusion criteria. Antioxidant agents that inhibit diabetic nephropathy can be classified as single antioxidants (silymarin, baicalin, epigallocatechin gallate, vitamin E, selenium, curcumin, α-lipoic acid, and tocotrienol-rich vitamin E) and combined antioxidants (α-lipoic acid with vitamin B6, and resveratrol with losartan). Antioxidant agents have been shown to reduce oxidative stress and inflammation, but their role in the progression of fibrosis remains unclear. The oxidative stress marker MDA was significantly reduced by silymarin, curcumin, vitamin E, tocotrienol-rich vitamin E, selenium, ALA, vitamin B, resveratrol and losartan. Silymarin was found to be the most effective (-3.43 µmol/L; 6.02 to 0.83). Compared to silymarin and epigallocatechin gallate, vitamin E was more effective (at -35.4 ng/L; P < 0.001) in reducing inflammation by decreasing TNF-α levels. In addition, tocotrienol-rich vitamin E, silymarin, baicalin, and selenium showed a decrease TGF-β levels, but did not show statistically significant differences between the placebo and intervention groups. Conclusion: Potential antioxidant agents, such as flavonoids, vitamins, fatty acids, and antioxidant minerals, were examined in this systematic review. These agents contribute to reducing markers of oxidative stress and hyperglycemia-induced inflammation. Although several antioxidants play a role in reducing fibrosis markers, the effect does not appear to be statistically significant.
- Open Access
- 1 May 2024
- Published by STKIP Persada Khatulistiwa in JPBIO (Jurnal Pendidikan Biologi)
- Vol. 9 (1) , 123-132
The Phytochemical constituents and biological activities of sungkai (Peronema canescens Jack) leaves hydroethanolic extracts
The Phytochemical constituents and biological activities of sungkai (Peronema canescens Jack) leaves hydroethanolic extracts
- 1 May 2024
- Published by STKIP Persada Khatulistiwa in JPBIO (Jurnal Pendidikan Biologi)
- Vol. 9 (1) , 123-132
Open AccessThe Phytochemical constituents and biological activities of sungkai (Peronema canescens Jack) leaves hydroethanolic extracts
The Phytochemical constituents and biological activities of sungkai (Peronema canescens Jack) leaves hydroethanolic extracts
- Open Access
- 30 November 2023
- Published by STKIP Persada Khatulistiwa in JPBIO (Jurnal Pendidikan Biologi)
- Vol. 8 (2) , 325-338
Health benefits of aqueous and ethanolic extracts of medinilla speciosa blume
Medinilla speciosa (local name: parijoto) has many pharmacological benefits, including for treating female infertility. This study aimed to identify bioactive compounds of the aqueous and ethanolic extracts of Medinilla speciosa; to find information on their pharmacological benefits, and to do its docking profile with the protein phosphatase1, which is associated with the enhancement of female fertility. Articles were searched from PubMed. The components of Medinilla speciosa were analyzed with LC-MS/MS. In silico study was conducted based PubChem, Protein Data Base, and Swiss ADME. Pyrx 0.8 and Discovery Studio Visualizer v21.1 were used to predict the interaction. Four flavonoids were identified, namely fisetin, robinetin, luteolin, and kaempferol. Except for robinetin, they exist in glycosidic form. One polyphenol, ellagic acid, was also identified. Literature studies showed they have various pharmacological benefits, such as antioxidants, anti-inflammation, anticancer, antidiabetes, organ protection, and antimicrobial. However, no information is available on its potential for fertility enhancement. Docking analysis showed that the bioactive compounds interact with the A and C chains of the catalytic domain of protein phosphatase 1 (PP1). Aqueous and ethanolic extracts of Medinilla speciosa possess fisetin, robinetin, luteolin, kaempferol, and ellagic acid that bind to catalytic chains of protein phosphatase 1.
- 30 November 2023
- Published by STKIP Persada Khatulistiwa in JPBIO (Jurnal Pendidikan Biologi)
- Vol. 8 (2) , 325-338
Open AccessHealth benefits of aqueous and ethanolic extracts of medinilla speciosa blume
Medinilla speciosa (local name: parijoto) has many pharmacological benefits, including for treating female infertility. This study aimed to identify bioactive compounds of the aqueous and ethanolic extracts of Medinilla speciosa; to find information on their pharmacological benefits, and to do its docking profile with the protein phosphatase1, which is associated with the enhancement of female fertility. Articles were searched from PubMed. The components of Medinilla speciosa were analyzed with LC-MS/MS. In silico study was conducted based PubChem, Protein Data Base, and Swiss ADME. Pyrx 0.8 and Discovery Studio Visualizer v21.1 were used to predict the interaction. Four flavonoids were identified, namely fisetin, robinetin, luteolin, and kaempferol. Except for robinetin, they exist in glycosidic form. One polyphenol, ellagic acid, was also identified. Literature studies showed they have various pharmacological benefits, such as antioxidants, anti-inflammation, anticancer, antidiabetes, organ protection, and antimicrobial. However, no information is available on its potential for fertility enhancement. Docking analysis showed that the bioactive compounds interact with the A and C chains of the catalytic domain of protein phosphatase 1 (PP1). Aqueous and ethanolic extracts of Medinilla speciosa possess fisetin, robinetin, luteolin, kaempferol, and ellagic acid that bind to catalytic chains of protein phosphatase 1.
- Open Access
- 18 April 2023
- Published by Universitas Kristen Krida Wacana in Jurnal MedScientiae
- Vol. 2 (1) , 12-16
Profil fitokimia dan aktivitas antioksidan dari minyak atsiri kulit buah Jeruk Pontianak (Citrus nobilis lour. var. Microcarpa)
. Citrus nobilis lour fruit. var. microcarpa (C. nobilis) or Pontianak Orange is a food source with good vitamins and antioxidants, while the peel was considered as waste. Along with technological development, people processed it by utilizing its essential oil. Research showed that the essential oil of Pontianak orange peel (C. nobilis) could inhibit the growth of some gram-positive and -negative bacteria. Still, the compounds' composition and antioxidant and anti-inflammatory properties have not been studied much. Therefore, this study aimed to determine the active compound composition, antioxidant, and anti-inflammatory activity of C. nobilis essential oil. The essential oil from C. nobilis peel was extracted using the clavenger method. The GCMS methods was used for active compound profiling. The antioxidant activity of essential oils was examined using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical. The dominant active compound components in C. nobilis essential oil were limonene, β-myrcene, and linalool. The essential oil of C. nobilis had robust antioxidant activity (IC50 13.114 µg/mL) compared to BHT. The content of the dominant active compound in the essential oil supported this activity.
- 18 April 2023
- Published by Universitas Kristen Krida Wacana in Jurnal MedScientiae
- Vol. 2 (1) , 12-16
Open AccessProfil fitokimia dan aktivitas antioksidan dari minyak atsiri kulit buah Jeruk Pontianak (Citrus nobilis lour. var. Microcarpa)
. Citrus nobilis lour fruit. var. microcarpa (C. nobilis) or Pontianak Orange is a food source with good vitamins and antioxidants, while the peel was considered as waste. Along with technological development, people processed it by utilizing its essential oil. Research showed that the essential oil of Pontianak orange peel (C. nobilis) could inhibit the growth of some gram-positive and -negative bacteria. Still, the compounds' composition and antioxidant and anti-inflammatory properties have not been studied much. Therefore, this study aimed to determine the active compound composition, antioxidant, and anti-inflammatory activity of C. nobilis essential oil. The essential oil from C. nobilis peel was extracted using the clavenger method. The GCMS methods was used for active compound profiling. The antioxidant activity of essential oils was examined using the 2,2-diphenyl-1-picrylhydrazyl (DPPH) free radical. The dominant active compound components in C. nobilis essential oil were limonene, β-myrcene, and linalool. The essential oil of C. nobilis had robust antioxidant activity (IC50 13.114 µg/mL) compared to BHT. The content of the dominant active compound in the essential oil supported this activity.
- Open Access
- 1 January 2023
- Published by Leaflet Publisher in Journal of Phytomolecules and Pharmacology
- Vol. 2 (2) , 83-94
An in silico ADME/T and molecular docking studies of C-glycosyl flavones derived from Peperomia blanda (Jacq.) Kunth for the management of diabetes
- 1 January 2023
- Published by Leaflet Publisher in Journal of Phytomolecules and Pharmacology
- Vol. 2 (2) , 83-94
Open AccessAn in silico ADME/T and molecular docking studies of C-glycosyl flavones derived from Peperomia blanda (Jacq.) Kunth for the management of diabetes
- Open Access
Phytochemical Analysis, Antimutagenic and Antiviral Activity of Moringa oleifera L. Leaf Infusion: In Vitro and In Silico Studies
Moringa oleifera (M. oleifera) leaves are rich in nutrients and antioxidant compounds that can be consumed to prevent and overcome malnutrition. The water infusion of its leaf is the easiest way to prepare the herbal drink. So far, no information is available on the antioxidant, antimutagenic, and antivirus capacities of this infusion. This study aimed to determine the composition of the bioactive compounds in M. oleifera leaf infusion, measuring for antioxidant and antimutagenic activity, and evaluating any ability to inhibit the SARS-CoV-2 main protease (Mpro). The first two objectives were carried out in vitro. The third objective was carried out in silico. The phytochemical analysis of M. oleifera leaf infusion was carried out using liquid chromatography-mass spectrometry (LC-MS). Antioxidant activity was measured as a factor of the presence of the free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH). The antimutagenicity of M. oleifera leaf powder infusion was measured using the plasmid pBR322 (treated free radical). The interaction between bioactive compounds and Mpro of SARS-CoV-2 was analyzed via molecular docking. The totals of phenolic compound and flavonoid compound from M. oleifera leaf infusion were 1.780 ± 5.00 µg gallic acid equivalent/g (µg GAE/g) and 322.91 ± 0.98 µg quercetin equivalent/g (µg QE/g), respectively. The five main bioactive compounds involved in the infusion were detected by LC-MS. Three of these were flavonoid glucosides, namely quercetin 3-O-glucoside, kaempferol 3-O-neohesperidoside, and kaempferol 3-α-L-dirhamnosyl-(1→4)-β-D-glucopyranoside. The other two compounds were undulatoside A, which belongs to chromone-derived flavonoids, and gentiatibetine, which belongs to alkaloids. The antioxidant activity of M. oleifera leaf infusion was IC50 8.19 ± 0.005 µg/mL, which is stronger than the standard butylated hydroxytoluene (BHT) IC50 11.60 ± 0.30 µg/mL. The infusion has an antimutagenic effect and therefore protects against deoxyribonucleic acid (DNA) damage. In silico studies showed that the five main bioactive compounds have an antiviral capacity. There were strong energy bonds between Mpro molecules and gentiatibetine, quercetin, undulatoside A, kaempferol 3-o-neohesperidoside, and quercetin 3-O-glucoside. Their binding energy values are −5.1, −7.5, −7.7, −5.7, and −8.2 kcal/mol, respectively. Their antioxidant activity, ability to maintain DNA integrity, and antimutagenic properties were more potent than the positive controls. It can be concluded that leaf infusion of M. oleifera does provide a promising herbal drink with good antioxidant, antimutagenic, and antivirus capacities.
Open AccessPhytochemical Analysis, Antimutagenic and Antiviral Activity of Moringa oleifera L. Leaf Infusion: In Vitro and In Silico Studies
Moringa oleifera (M. oleifera) leaves are rich in nutrients and antioxidant compounds that can be consumed to prevent and overcome malnutrition. The water infusion of its leaf is the easiest way to prepare the herbal drink. So far, no information is available on the antioxidant, antimutagenic, and antivirus capacities of this infusion. This study aimed to determine the composition of the bioactive compounds in M. oleifera leaf infusion, measuring for antioxidant and antimutagenic activity, and evaluating any ability to inhibit the SARS-CoV-2 main protease (Mpro). The first two objectives were carried out in vitro. The third objective was carried out in silico. The phytochemical analysis of M. oleifera leaf infusion was carried out using liquid chromatography-mass spectrometry (LC-MS). Antioxidant activity was measured as a factor of the presence of the free radical 2,2-diphenyl-1-picrylhydrazyl (DPPH). The antimutagenicity of M. oleifera leaf powder infusion was measured using the plasmid pBR322 (treated free radical). The interaction between bioactive compounds and Mpro of SARS-CoV-2 was analyzed via molecular docking. The totals of phenolic compound and flavonoid compound from M. oleifera leaf infusion were 1.780 ± 5.00 µg gallic acid equivalent/g (µg GAE/g) and 322.91 ± 0.98 µg quercetin equivalent/g (µg QE/g), respectively. The five main bioactive compounds involved in the infusion were detected by LC-MS. Three of these were flavonoid glucosides, namely quercetin 3-O-glucoside, kaempferol 3-O-neohesperidoside, and kaempferol 3-α-L-dirhamnosyl-(1→4)-β-D-glucopyranoside. The other two compounds were undulatoside A, which belongs to chromone-derived flavonoids, and gentiatibetine, which belongs to alkaloids. The antioxidant activity of M. oleifera leaf infusion was IC50 8.19 ± 0.005 µg/mL, which is stronger than the standard butylated hydroxytoluene (BHT) IC50 11.60 ± 0.30 µg/mL. The infusion has an antimutagenic effect and therefore protects against deoxyribonucleic acid (DNA) damage. In silico studies showed that the five main bioactive compounds have an antiviral capacity. There were strong energy bonds between Mpro molecules and gentiatibetine, quercetin, undulatoside A, kaempferol 3-o-neohesperidoside, and quercetin 3-O-glucoside. Their binding energy values are −5.1, −7.5, −7.7, −5.7, and −8.2 kcal/mol, respectively. Their antioxidant activity, ability to maintain DNA integrity, and antimutagenic properties were more potent than the positive controls. It can be concluded that leaf infusion of M. oleifera does provide a promising herbal drink with good antioxidant, antimutagenic, and antivirus capacities.
- Open Access
- 19 April 2021
- Published by Hanif Medisiana Publisher in Eureka Herba Indonesia
- Vol. 2 (2) , 93-103
Antibacterial and Antifungal Activity of Clove Extract (Syzygium Aromaticum): Review
Cloves is one of the native Indonesian plants and is used in many aspects of life. Cloves are used in multiple industries and as detergents, soaps, perfumes, food seasonings, aromatherapy, etc. Cloves are mainly used for ingredients in kretek cigarettes in Indonesia. Various studies of cloves reported they have good pharmacological and therapeutic effects. The main compounds of clove extract are eugenol and β-caryophyllene, which are powerful antibacterial and antifungal agents. The clove ethanolic extract showed the activity to inhibit Gram positive and negative bacteria such as B. cereus, S. aureus, E. coli, P. aeruginosa, S. pneumoniae, S. aureus, S. epidermidis, A. hydrophila, K. pneumoniae, P. gingivalis, and P. mirabilis. Clove essential oil has shown the ability to inhibit the growth of V. inaequalis, C. albicans, C. glabrata, and C. tropicalis. Cloves extract can be used as an essential ingredient of various medicines. However, it requires further research and trials.
- 19 April 2021
- Published by Hanif Medisiana Publisher in Eureka Herba Indonesia
- Vol. 2 (2) , 93-103
Open AccessAntibacterial and Antifungal Activity of Clove Extract (Syzygium Aromaticum): Review
Cloves is one of the native Indonesian plants and is used in many aspects of life. Cloves are used in multiple industries and as detergents, soaps, perfumes, food seasonings, aromatherapy, etc. Cloves are mainly used for ingredients in kretek cigarettes in Indonesia. Various studies of cloves reported they have good pharmacological and therapeutic effects. The main compounds of clove extract are eugenol and β-caryophyllene, which are powerful antibacterial and antifungal agents. The clove ethanolic extract showed the activity to inhibit Gram positive and negative bacteria such as B. cereus, S. aureus, E. coli, P. aeruginosa, S. pneumoniae, S. aureus, S. epidermidis, A. hydrophila, K. pneumoniae, P. gingivalis, and P. mirabilis. Clove essential oil has shown the ability to inhibit the growth of V. inaequalis, C. albicans, C. glabrata, and C. tropicalis. Cloves extract can be used as an essential ingredient of various medicines. However, it requires further research and trials.
- Open Access
- 29 March 2021
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 2346 (1) , 020006
Pre-clinical test for non-invasive (in vitro) blood glucose levels measuring at visible light wavelengths
The wavelength convention for non-invasive blood glucose measurement remains inconclusive. We have done this experimental observation to measure wavelength candidate performance for non-invasive blood glucose level measurement optical device in the visible range. We run this observation in Electronic Material Physics Lab, IPB University, Bogor, July 2019. We have measured two levels the blood glucose level control in cuvettes using LEDs and photodiodes from Thorlabs. The LEDs are between 450 nm to 670 nm. BioRad has provided The 100 mg/dl and 3030 mg/dl blood glucose level control for this study. We have modulated The LEDs intensity in 10 different values in a ladder setting. We have used a custom made probe to make sure there is no residual light effect from the environment. We have analysed the photodiodes readings using multi formulated regression to find the appropriate equation for predicting blood glucose level. We have found that LED in 645 nm wavelength gave the highest accuracy at 0.71. The second highest accuracy is 0.70 by LED 610 nm. The R^2 value is 0.97. We concluded that LED 645 nm might appropriate for non-invasive blood glucose level measurement optical device. Further research shall confirm this trial with human observation.
- 29 March 2021
- Published by AIP Publishing in AIP Conference Proceedings
- Vol. 2346 (1) , 020006
Open AccessPre-clinical test for non-invasive (in vitro) blood glucose levels measuring at visible light wavelengths
The wavelength convention for non-invasive blood glucose measurement remains inconclusive. We have done this experimental observation to measure wavelength candidate performance for non-invasive blood glucose level measurement optical device in the visible range. We run this observation in Electronic Material Physics Lab, IPB University, Bogor, July 2019. We have measured two levels the blood glucose level control in cuvettes using LEDs and photodiodes from Thorlabs. The LEDs are between 450 nm to 670 nm. BioRad has provided The 100 mg/dl and 3030 mg/dl blood glucose level control for this study. We have modulated The LEDs intensity in 10 different values in a ladder setting. We have used a custom made probe to make sure there is no residual light effect from the environment. We have analysed the photodiodes readings using multi formulated regression to find the appropriate equation for predicting blood glucose level. We have found that LED in 645 nm wavelength gave the highest accuracy at 0.71. The second highest accuracy is 0.70 by LED 610 nm. The R^2 value is 0.97. We concluded that LED 645 nm might appropriate for non-invasive blood glucose level measurement optical device. Further research shall confirm this trial with human observation.